|
| View:
Latest News | Top Stories |
|
| 1.
|
Alkermes Drug Gets Priority FDA Review
-
AP
-
Fri May 27, 2005
Pharmaceutical company Alkermes Inc. on Friday said its new drug application for its alcohol dependence medication has been accepted and granted a priority review by the Food and Drug Administration.
|
|
| 2.
|
Biovail Gets Tentative FDA OK for Pill
-
AP
-
Fri May 27, 2005
Canadian pharmaceutical company Biovail Corp. said Friday that it received tentative approval from the Food and Drug Administration for an orally-disintegrating version of Sanofi-Aventis SA's Ambien sleeping pill.
|
|
| 3.
|
Market Pulse: Biovail gets tentative ok for generic version of Ambien
-
at MarketWatch
-
Fri May 27, 2005
|
|
| 4.
|
Santarus Submits New Drug Application for ZEGERID Chewable Tablets
-
Business Wire
-
Fri May 27, 2005
Santarus, Inc. , a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, today announced that it has submitted a New Drug Application for ZEGERID Chewable Tablets 40 mg and 20 mg to the U.S.
|
|
| 5.
|
Neurocrine Announces Submission of New Drug Application for Indiplon Tablets
-
PR Newswire
-
Thu May 26, 2005
Neurocrine Biosciences, Inc. announced that the company has completed submission of a New Drug Application to the U.S. Food and Drug Administration for indiplon tablets for the treatment of insomnia in both adult and elderly patients.
|
|
| 6.
|
FDA Approves IND for Elite Pharmaceuticals Abuse-Resistant Oxycodone Product
-
PR Newswire
-
Thu May 26, 2005
Elite Pharmaceuticals, Inc. announced that the FDA has approved the Company's investigational new drug application for its abuse-resistant oxycodone product.
|
|
| 7.
|
Elan Holds Its Ground
-
Motley Fool
-
Thu May 26, 2005
Elan clearly isn't throwing in the towel on Tysabri, but its fate is not solely in the company's hands.
|
|
| 8.
|
Flu Vaccines' Unhealthy Competition
-
Motley Fool
-
Thu May 26, 2005
New competitors in the flu-fighting niche could make all companies worse off.
|
|
| 9.
|
Market Pulse: Eyetech upped at Thomas Weisel, Lucentis cited
-
at MarketWatch
-
Thu May 26, 2005
|
|
| 10.
|
Law Firm Shalov Stone & Bonner LLP Announces Class Action Lawsuit Against Able Laboratories, Inc.
-
Business Wire
-
Wed May 25, 2005
On May 24, 2005, a class action was commenced on behalf of all persons who purchased the securities of Able Laboratories, Inc. , in the period from May 6, 2003, through May 18, 2005.
|
|
